Skip to main content
. 2005 Apr 5;92(8):1517–1523. doi: 10.1038/sj.bjc.6602532

Table 2. Clinical characteristics.

Patients' samples Age (years) Sex Leucocytes count Binet stage Additional malignancies in the past
CLL 1 71 Female 22 450 B None
CLL 2 62 Male 16 730 B None
CLL 3 63 Female 18 680 A None
CLL 4 75 Male 139 900 B None
CLL 5 74 Female 19 000 A Basal cell carcinoma of skin
CLL 6 72 Female 27 300 A None
CLL 7 54 Female 63 800 A Basal cell carcinoma of skin
CLL 8 74 Male 30 000 A Basal cell carcinoma of skin
CLL 9 69 Female 31 300 A None
CLL 10 72 Male 23 270 A None
CLL 11 79 Male 73 300 B Squamous cell papilloma
CLL 12 73 Male 46 760 B Adenocarcinoma of prostate, Tubular adenoma of colon × 3
CLL 13 74 Male 81 810 C None
CLL 14 81 Male 46 180 C Adenocarcinoma of stomach
CLL 15 68 Male 80 180 C Basal cell carcinoma of skin × 6, Squamous cell carcinoma of skin
CLL 16 59 Male 34 000 A None
CLL 17 68 Female 24 130 A None
CLL 18 74 Female 19 000 A None
CLL 19 62 Female 24 000 A None
CLL 20 79 Male 24 500 A None
CLL 21 86 Male 37 000 B Adenocarcinoma of colon
CLL 22 68 Male 12 170 A None
CLL 23 70 Male 19 000 A None
CLL 24 53 Male 61 240 A None
CLL 25 45 Female 479 000 C None
CLL 26 82 Male 20 000 A None
CLL 27 76 Male 157 600 C None